Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

anemia/cansancio

El enlace se guarda en el portapapeles.
Página 1 desde 17 resultados

Selective androgen receptor modulators

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION The present invention relates to androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity, which are nonsteroidal ligands for the androgen receptor. The agents are useful for a) male contraception; b) treatment of a variety of hormone-related

Selective androgen receptor modulators

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION The present invention relates to androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity, which are nonsteroidal ligands for the androgen receptor. The agents are useful for a) male contraception; b) treatment of a variety of hormone-related

Formulations comprising selective androgen receptor modulators

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION The present invention relates to pharmaceutical compositions and formulations comprising a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new

Multi-substituted selective androgen receptor modulators and methods of use thereof

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION The present invention relates to androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds, which are selective androgen receptor modulators

Multi-substitued selective androgen receptor modulators and methods of use thereof

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds, which are selective androgen receptor

Methylene-bridged selective androgen receptor modulators and methods of use thereof

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which are selective androgen receptor modulators (SARM). The SARM compounds are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example

Heterocyclic selective androgen receptor modulators and methods of use thereof

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which are selective androgen receptor modulators (SARM). The SARM compounds are useful for a) male contraception; b) treatment of a variety of hormone-related conditions, for example

Halogenated selective androgen receptor modulators and methods of use thereof

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds, which are selective androgen receptor

Selective androgen receptor modulators and methods of use thereof

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds, which are selective androgen receptor

N-bridged selective androgen receptor modulators and methods of use thereof

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION The present invention relates to a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of compounds, which are selective androgen receptor

Synthesis of selective androgen receptor modulators

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION The present invention relates to a synthetic process for the preparation of a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of

Synthesis of selective androgen receptor modulators

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
FIELD OF INVENTION The present invention relates to a synthetic process for the preparation of a novel class of androgen receptor targeting agents (ARTA), which demonstrate androgenic and anabolic activity of a nonsteroidal ligand for the androgen receptor. The agents define a new subclass of

Method for the management of cancer and cancer treatment-related comorbidities

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
TECHNICAL FIELD The invention concerns a method for the management of cancer and treatment cancer comorbidities, including but not limited to cancer-related fatigue, cachexia, anorexia, pain, anemia, asthenia, depression, impaired cognitive function, loss of appetite, muscle weakness, nausea,

Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
TECHNICAL FIELD The present invention relates to the field of therapeutic uses for erythropoietin, and more particularly, to treating subjects with a recombinant erythropoietin prepared from an Apa I human genomic DNA fragment, including recombinant erythropoietin expressed in transformed baby

Treatment of diseases caused by viral infection

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to the treatment of diseases caused by viral infection. More precisely, the invention relates to a method of prophylactic and/or therapeutic treatment of a mammal for a disease. The disease may be caused by viral infection
Únete a nuestra
página de facebook

La base de datos de hierbas medicinales más completa respaldada por la ciencia

  • Funciona en 55 idiomas
  • Curas a base de hierbas respaldadas por la ciencia
  • Reconocimiento de hierbas por imagen
  • Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
  • Leer publicaciones científicas relacionadas con su búsqueda
  • Buscar hierbas medicinales por sus efectos.
  • Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.

Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.

Google Play badgeApp Store badge